2138 — EC Healthcare Share Price
- HK$746.68m
- HK$1.95bn
- HK$4.21bn
- 68
- 88
- 25
- 67
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 63 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | 12.86% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.37 | ||
Price to Tang. Book | 1.73 | ||
Price to Free Cashflow | 1.18 | ||
Price to Sales | 0.18 | ||
EV to EBITDA | 2.49 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 3.7% | ||
Return on Equity | -0.59% | ||
Operating Margin | 3.5% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 1,948.5 | 2,080.4 | 2,919.5 | 3,875.38 | 4,211.03 | 4,443 | 4,749 | 17.85% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -21.76 | -61.51 | +38.48 | -82.33 | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
EC Healthcare is an investment holding company principally engaged in the provision of medical and healthcare services. The Company operates its business through three segments. The Medical Services segment provides medical services,dental services and others. The Aesthetic Medical and Beauty and Wellness segment provides aesthetic medicine, traditional beauty, hair care and supplemental wellness services and sale of skin care, health and beauty products. The Other segment provides marketing and related services and veterinary services.
Directors
- Chi Fai Tang CHM (42)
- Lu Lyn Leslie CCE (41)
- Lyn Wade Lu CCE (41)
- Ka Ki Wong CIN (40)
- Yeung Cheng GMG (44)
- Heung Wing Lee EDR (38)
- Chi Cheung Wong EDR (47)
- Chun Pong Siu SEC (41)
- Kun Shing Ben Luk NED (36)
- Chi Hang Lam NID (40)
- Andrew Look NID (51)
- Ching Nam Ma NID (67)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- July 7th, 2015
- Public Since
- March 11th, 2016
- No. of Employees
- 2,872
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,185,211,265

- Address
- 20/F, Devon House, Taikoo Place,
- Web
- https://echealthcare.com/
- Phone
- +852 null39754798
- Auditors
- Ernst & Young
Latest News for 2138
Upcoming Events for 2138
EC Healthcare Annual Shareholders Meeting
Similar to 2138
Anxian Yuan China Holdings
Stock Exchange of Hong Kong Limited
BaWang International Holding
Stock Exchange of Hong Kong Limited
Beauty Farm Medical & Health Industry
Stock Exchange of Hong Kong Limited
China Beststudy Education
Stock Exchange of Hong Kong Limited
BExcellent group
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 20:22 UTC, shares in EC Healthcare are trading at HK$0.63. This share price information is delayed by 15 minutes.
Shares in EC Healthcare last closed at HK$0.63 and the price had moved by -49.19% over the past 365 days. In terms of relative price strength the EC Healthcare share price has underperformed the FTSE Developed Asia Pacific Index by -47.75% over the past year.
The overall consensus recommendation for EC Healthcare is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe EC Healthcare dividend yield is 1.59% based on the trailing twelve month period.
Last year, EC Healthcare paid a total dividend of HK$0.01, and it currently has a trailing dividend yield of 1.59%. We do not have any data on when EC Healthcare is to next pay dividends.
We do not have data on when EC Healthcare is to next pay dividends. The historic dividend yield on EC Healthcare shares is currently 1.59%.
To buy shares in EC Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.63, shares in EC Healthcare had a market capitalisation of HK$746.68m.
Here are the trading details for EC Healthcare:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2138
Based on an overall assessment of its quality, value and momentum EC Healthcare is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in EC Healthcare is HK$4.00. That is 534.92% above the last closing price of HK$0.63.
Analysts covering EC Healthcare currently have a consensus Earnings Per Share (EPS) forecast of HK$0.01 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EC Healthcare. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -13.56%.
As of the last closing price of HK$0.63, shares in EC Healthcare were trading -22.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The EC Healthcare PE ratio based on its reported earnings over the past 12 months is 63. The shares last closed at HK$0.63.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
EC Healthcare's management team is headed by:
- Chi Fai Tang - CHM
- Lu Lyn Leslie - CCE
- Lyn Wade Lu - CCE
- Ka Ki Wong - CIN
- Yeung Cheng - GMG
- Heung Wing Lee - EDR
- Chi Cheung Wong - EDR
- Chun Pong Siu - SEC
- Kun Shing Ben Luk - NED
- Chi Hang Lam - NID
- Andrew Look - NID
- Ching Nam Ma - NID